Antifibrotics in interstitial lung disease related to connective tissue diseases - a paradigm shift in treatment and outcome
Interstitial lung disease (ILD) is one of the major causes of morbidity and mortality in patients with connective tissue disease (CTD) and the treatments available until nowadays are in most cases unable to halt disease progression. CTD-ILD pathogenesis includes an initial inflammatory phase, fol...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Portuguesa de Reumatologia
2019-04-01
|
| Series: | Acta Reumatológica Portuguesa |
| Subjects: | |
| Online Access: | http://www.actareumatologica.com/files/article/1255_antifibrotics_in_interstitial_lung_disease_related_to_connective_tissue_diseases_a_paradigm_shift_in_treatment_and_outcome__file.pdf |